These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24402780)

  • 1. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design.
    Xu S; Newcomer S; Nelson J; Qian L; McClure D; Pan Y; Zeng C; Glanz J
    Biom J; 2014 May; 56(3):513-25. PubMed ID: 24402780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample.
    Xu S; Clarke CL; Newcomer SR; Daley MF; Glanz JM
    Biom J; 2018 Jul; 60(4):748-760. PubMed ID: 29768667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.
    Glanz JM; Newcomer SR; Hambidge SJ; Daley MF; Narwaney KJ; Xu S; Lee GM; Baggs J; Klein NP; Nordin JD; Naleway AL; Belongia EA; Weintraub ES
    Arch Pediatr Adolesc Med; 2011 Aug; 165(8):749-55. PubMed ID: 21810637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept study.
    Van Holle L; Zeinoun Z; Bauchau V; Verstraeten T
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):603-10. PubMed ID: 22383219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
    Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters.
    Mullooly JP; Crane B; Chun C
    Vaccine; 2006 Mar; 24(13):2256-63. PubMed ID: 16375995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
    Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
    Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of the trivalent inactivated influenza vaccine among children: a population-based study.
    France EK; Glanz JM; Xu S; Davis RL; Black SB; Shinefield HR; Zangwill KM; Marcy SM; Mullooly JP; Jackson LA; Chen R
    Arch Pediatr Adolesc Med; 2004 Nov; 158(11):1031-6. PubMed ID: 15520339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children.
    Newcomer SR; Hambidge SJ; McClure DL; Daley MF; Klein NP; Glanz JM
    Vaccine; 2013 Aug; 31(37):3894-8. PubMed ID: 23831326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying optimal risk windows for self-controlled case series studies of vaccine safety.
    Xu S; Zhang L; Nelson JC; Zeng C; Mullooly J; McClure D; Glanz J
    Stat Med; 2011 Mar; 30(7):742-52. PubMed ID: 21394750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
    Kawai AT; Li L; Kulldorff M; Vellozzi C; Weintraub E; Baxter R; Belongia EA; Daley MF; Jacobsen SJ; Naleway A; Nordin JD; Lee GM
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):548-53. PubMed ID: 24497128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative incidence estimation from case series for vaccine safety evaluation.
    Farrington CP
    Biometrics; 1995 Mar; 51(1):228-35. PubMed ID: 7766778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design.
    Zeng C; Newcomer SR; Glanz JM; Shoup JA; Daley MF; Hambidge SJ; Xu S
    Am J Epidemiol; 2013 Dec; 178(12):1750-9. PubMed ID: 24327463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic actions of the risks and adverse events associated with vaccine administration.
    Moylett EH; Hanson IC
    J Allergy Clin Immunol; 2004 Nov; 114(5):1010-20; quiz 1021. PubMed ID: 15536401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous sequential boundaries for vaccine safety surveillance.
    Li R; Stewart B; Weintraub E; McNeil MM
    Stat Med; 2014 Aug; 33(19):3387-97. PubMed ID: 24691986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vaccine Safety Datalink: a model for monitoring immunization safety.
    Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
    Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events.
    Kharbanda EO; Vazquez-Benitez G; Lipkind H; Naleway A; Lee G; Nordin JD;
    Obstet Gynecol; 2013 Sep; 122(3):659-67. PubMed ID: 23921876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006.
    Abrams JY; Weintraub ES; Baggs JM; McCarthy NL; Schonberger LB; Lee GM; Klein NP; Belongia EA; Jackson ML; Naleway AL; Nordin JD; Hambidge SJ; Belay ED
    Vaccine; 2015 Jan; 33(2):382-7. PubMed ID: 25444786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.